Key result
CCTA accurately measures Mg-BRS minimal in-stent diameter, matching post-PCI QCA measurements.
Why the study?
To assess clinical and CCTA medium- and long-term follow-up of patients with implanted magnesium-based bioresorbable stents.
Does CCTA accurately assess in-scaffold luminal dimensions without blooming artifacts compared to QCA in patients with implanted magnesium-based bioresorbable stents?
Cross-Sectional (n=44)
No
Does CCTA accurately assess in-scaffold luminal dimensions without blooming artifacts compared to QCA in patients with implanted magnesium-based bioresorbable stents?
Answers are grounded in this paper and cite their sources.
CCTA is a feasible and accurate non-invasive imaging modality for follow-up of magnesium-based bioresorbable stents, allowing precise luminal assessment without the blooming artifacts seen in metallic stents.
(1) Background: The diagnostic accuracy of coronary computed tomography angiography (CCTA) for coronary artery disease (CAD) has greatly improved so CCTA represents a transition in the care of patients suffering from CAD. Magnesium-based bioresorbable stents (Mg-BRS) secure acute percutaneous coronary intervention (PCI) results without leaving, in the long term, a metallic caging effect. The purpose of this real-world study was to assess clinical and CCTA medium- and long-term follow-up of all our patients with implanted Mg-BRS. (2) Methods: The patency of 52 Mg-BRS implanted in 44 patients with de novo lesions (24 of which had acute coronary syndrome (ACS)) was evaluated by CCTA and compared to quantitative coronary angiography (QCA) post-implantation. (3) Results: ten events including four deaths occurred during a median follow-up of 48 months. CCTA was interpretable and in-stent measurements were successful at follow-up without being hindered by the stent strut’s “blooming effect”. Minimal in-stent diameters on CCTA were found to be 1.03 ± 0.60 mm smaller than the expected diameter after post-dilation on implantation (p < 0.05), a difference not found in comparing CCTA and QCA. (4) Conclusions: CCTA follow-up of implanted Mg-BRS is fully interpretable and we confirm the long-term Mg-BRS safety profile.
No takes yet. Share an insight, caveat, or question.
Ghafari et al. (2023) conducted a cross-sectional in Coronary artery disease (de novo lesions) (n=44). Coronary computed tomography angiography (CCTA) vs. Quantitative coronary angiography (QCA) post-implantation was evaluated on Minimal in-stent diameter by CCTA compared to post-PCI QCA minimal lumen diameter (Mean difference -0.08 mm, p=NS). CCTA accurately evaluated Mg-BRS with a mean minimal in-stent diameter of 2.38 mm, showing no significant difference compared to the 2.4 mm measured by post-PCI QCA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: